Amicus Therapeutics Inc. buy Needham & Company LLC
Start price
18.09.25
/
50%
€7.20
Target price
18.09.26
€11.85
Performance (%)
70.83%
Price
12.01.26
€12.10
Summary
This prediction is currently active. With a performance of 70.83% the BUY prediction by Needham___Company_LL is a big success. This prediction currently runs until 18.09.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | 1.667% | 1.667% |
| iShares Core DAX® | 2.331% | 5.140% |
| iShares Nasdaq 100 | 2.077% | 2.956% |
| iShares Nikkei 225® | 2.759% | 7.214% |
| iShares S&P 500 | 1.613% | 2.893% |
Comments by Needham___Company_LL for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat